Results of lumbar spondylodeses using different bone grafting materials after transforaminal lumbar interbody fusion (TLIF)
- PMID: 28547573
- DOI: 10.1007/s00586-017-5145-0
Results of lumbar spondylodeses using different bone grafting materials after transforaminal lumbar interbody fusion (TLIF)
Abstract
Purpose: Can a mixture of hydroxyapatite (HA) and autologous bone from decompression sites produce similar results when used for transforaminal lumbar interbody fusion (TLIF)? In the current literature, autologous iliac crest bone grafts (ICBGs) have been reported the gold standard for this procedure. Indeed, to date, no clinical data have confirmed that a mixture of equal volumes of HA and local autologous bone produce similar results in term of fusion as the same volume of autologous ICBG alone.
Methods: Study design/setting This study was approved by the local ethics committee and completed in a prospective, randomized, single-blinded manner. The results of lumbar fusion using TLIF and different bone grafting materials were compared. Patient sample The patient sample included patients with spinal lumbar degenerative disease. Outcome measures The clinical outcome was determined using the Oswestry Low Back Pain Disability Questionnaire (ODI) and Visual Analog Scale (VAS). The radiological outcomes and fusion rates were determined with radiographs evaluated using the McAfee criteria and computed tomography (CT) data evaluated by the Williams criteria. Three blinded investigators (one radiologist and two orthopedic surgeons) assessed the data. The secondary variables included donor site morbidity. Methods The patients were admitted to our department for orthopedic surgery with degenerative lumbar pathologies (L2-S1) that required stabilization in one or two segments using a TLIF procedure. The patients were 18-80 years old. Only those patients who had degenerative lumbar pathologies and agreed to be educated about the study were included. The patients were divided into the following two randomized groups: group A: TLIF procedure using autologous ICBGs alone; and group B: TLIF procedure using local bone from decompression site mixed with hydroxyapatite. Each group received equal graft volumes. The mixture in group B consisted of equal volumes of local autograft (5 cc) and synthetic bone (5 cc). A graft volume of 10 cc was used at each fusion level. The patients were followed up at three appointments at 1.5, 6 and 12 months postoperatively. Every patient received detailed education about the course of the study.
Results: Forty-eight patients finished the study (2 patients dropped out). The radiographic fusion rate did not significantly differ between the two groups. Based on the CT criteria, 83.3% of the patients showed fusion in both groups after 12 months. Furthermore, 95.3% of the patients in group A and 91.7% of the patients in group B showed bony spondylodeses according to the radiographic criteria at the 12-month follow-up. The donor site morbidity consisted of one patient with a wound infection and one with a hematoma in group A and two patients with persistent pain in group B. Group A also included one patient with cage subsidence of 4 mm and archived fusion after 12 months. In group B, one patient had a pedicle screw breakage and achieved fusion after 6 months. The clinical outcomes were similar between the two groups. In both groups, the VAS and ODI data improved during the follow-up period (p < 0.05). No patients required additional surgeries.
Conclusions: Both groups demonstrated equivalent clinical outcomes. HA and autologous bone from decompression sites can achieve similar fusion rates to those achieved with identical volumes of the gold standard autologous graft. The graft mixture can be used for one- or two-level lumbar spondylodeses to avoid donor site morbidity.
Keywords: Bone graft; Fusion rate; Hydroxyapatite; Iliac crest; TLIF.
Similar articles
-
Comparing the early efficacies of autologous bone grafting and interbody fusion cages for treating degenerative lumbar instability in patients of different ages.Int Orthop. 2016 Jun;40(6):1211-8. doi: 10.1007/s00264-016-3124-4. Epub 2016 Feb 1. Int Orthop. 2016. PMID: 26830783
-
Twelve-month results of a multicenter, blinded, pilot study of a novel peptide (B2A) in promoting lumbar spine fusion.J Neurosurg Spine. 2015 Apr;22(4):358-66. doi: 10.3171/2013.11.SPINE121106. Epub 2015 Jan 23. J Neurosurg Spine. 2015. PMID: 25615629 Clinical Trial.
-
Clinical and radiographic outcomes using local bone shavings as autograft in minimally invasive transforaminal lumbar interbody fusion.World Neurosurg. 2012 Jul;78(1-2):185-90. doi: 10.1016/j.wneu.2011.05.049. Epub 2011 Nov 7. World Neurosurg. 2012. PMID: 22120378
-
Guideline update for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 16: bone graft extenders and substitutes as an adjunct for lumbar fusion.J Neurosurg Spine. 2014 Jul;21(1):106-32. doi: 10.3171/2014.4.SPINE14325. J Neurosurg Spine. 2014. PMID: 24980593 Review.
-
Radiographic and Clinical Outcomes of Anterior and Transforaminal Lumbar Interbody Fusions: A Systematic Review and Meta-analysis of Comparative Studies.Clin Spine Surg. 2018 May;31(4):E230-E238. doi: 10.1097/BSD.0000000000000549. Clin Spine Surg. 2018. PMID: 28622187
Cited by
-
Local Autograft Versus Iliac Crest Bone Graft PSF-Augmented TLIF in Low-Grade Isthmic and Degenerative Lumbar Spondylolisthesis.Global Spine J. 2022 Jan;12(1):70-78. doi: 10.1177/2192568220946319. Epub 2020 Sep 11. Global Spine J. 2022. PMID: 32914652 Free PMC article.
-
Characteristics of interbody bone graft fusion after transforaminal lumbar interbody fusion according to intervertebral space division.Front Surg. 2022 Oct 25;9:1004230. doi: 10.3389/fsurg.2022.1004230. eCollection 2022. Front Surg. 2022. PMID: 36386508 Free PMC article.
-
Transforaminal lumbar interbody fusion with a silicon nitride cage demonstrates early radiographic fusion.J Spine Surg. 2022 Mar;8(1):29-43. doi: 10.21037/jss-21-115. J Spine Surg. 2022. PMID: 35441113 Free PMC article.
-
Application of nano-hydroxyapatite matrix graft in inter-vertebral fusion therapy: a meta-analysis.BMC Musculoskelet Disord. 2023 May 27;24(1):427. doi: 10.1186/s12891-023-06405-x. BMC Musculoskelet Disord. 2023. PMID: 37245034 Free PMC article.
-
Low-frequency electromagnetic fields combined with tissue engineering techniques accelerate intervertebral fusion.Stem Cell Res Ther. 2021 Feb 17;12(1):143. doi: 10.1186/s13287-021-02207-x. Stem Cell Res Ther. 2021. PMID: 33597006 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical